A comparative pharmacokinetic study of carbamazepine when taken with water and thickened water in healthy adult males.

未提供0 个研究点目标入组 6 人开始时间: 待定最近更新: 2025年4月1日

试验速览

暂无简介。

•Age: The applicant must be at least 20 years old and less than 45 years old at the time of obtaining consent.
•Gender: Male
•Who have the capacity to give consent, abide by the rules of compliance during participation in the research, and are able to undergo the pre-test specified in the research protocol, and report subjective symptoms, etc.
•Those who have been judged eligible for participation in this study by the pysician in charge of the research or othewe relevant personnel based on a preliminary examination as stipulated in the research protocol.

•Persons with a medical history (drug abuse/dependence, alcohol abuse/dependence, heart, liver, kidney, lung, eye, or blood disease, etc.) that may affect the evaluation and safety of this study.
•Persons with hypothyroidism or a history of such disorders.
•Persons with epilepsy or other convulsive disorders or a history of such disorders.
•Persons with dysuria or ocular hypertension, etc.
•Persons taking medications (including supplements and dietary supplements) that may affect the
•evaluation and safety of this study.
•Persons with a history of drug allergy.
•Persons who regularly use excessive amounts of alcohol (those who cannot maintain abstinence from alcohol during the study period)
•Those who wish their partner to become pregnant during the study period.
•Persons with a history of drug eruptions caused by carbamazepine in the individual or their family.
•Those who are within three months of participating in another clinical research study.
•Any other person who judges by the investigator to be ineligible for the study.

Pharmacokinetic parameters of Carbamazepine in Primary Outcome serum (AUC0-24,Cmax)

未报告次要终点

发起方

未提供